# Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer

> **NCT00057837** · PHASE2 · COMPLETED · sponsor: **Eastern Cooperative Oncology Group** · enrollment: 140 (actual)

## Conditions studied

- Extensive Stage Small Cell Lung Cancer

## Interventions

- **BIOLOGICAL:** G-CSF
- **DRUG:** Cisplatin
- **DRUG:** Etoposide
- **DRUG:** Irinotecan
- **DRUG:** Topotecan

## Key facts

- **NCT ID:** NCT00057837
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07-14
- **Primary completion:** 2012-01
- **Final completion:** 2012-08
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2023-07-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00057837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00057837, "Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00057837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*